ArticleACS omega2025
Preparation and Application of a Zinc Oxide/Microcrystalline Cellulose Composite as a Cure Activator in Comparison with a Commercial Zinc Oxide Composite.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to synthesize a new grade of ZnO composite by depositing nanosized ZnO on microcrystalline cellulose (MCC), named MCC-ZnO, and compared its performance as a cure activator with an existing commercial ZnO composite using inorganic nanoparticles as a supporting core, named herein as In-ZnO. The results reveal that the synthesized MCC-ZnO consisted of approximately 50% wt. of nanosized ZnO, whereas the commercial one contained approximately 60% wt. When incorporated into styrene-butadiene rubber (SBR), both ZnO composites performed effectively as cure activators, resulting in decreases in scorch time and cure time in association with an increase in torque difference (state of cure). At a given content, MCC-ZnO showed superior cure activation efficacy to In-ZnO, as evidenced by the higher torque difference, which may be attributed to the smaller particle size of ZnO in MCC-ZnO. Regardless of the ZnO composite type, tensile strength, hardness, and modulus kept increasing as the ZnO composite content increased up to 5 phr. Tear strength also increased and reached its maximum at 3 phr for both ZnO composites. The results clearly reveal the potential of using MCC-ZnO to replace conventional ZnO in the production of more environmentally friendly rubber products.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.